Italia markets close in 4 hours 37 minutes

Calliditas Therapeutics AB (publ) (0A5R.L)

LSE - LSE Prezzo differito. Valuta in SEK.
Aggiungi a watchlist
98,40+0,80 (+0,82%)
Al 10:49AM GMT. Mercato aperto.
Schermo intero
Chiusura precedente97,60
Denaro0,00 x N/D
Lettera0,00 x N/D
Min-Max giorno98,40 - 101,70
Intervallo di 52 settimane98,40 - 101,70
Media VolumeN/D
Beta (5 anni mensile)1,30
Rapporto PE (ttm)N/D
EPS (ttm)-11,21
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    IgA Nephropathy Takes Center Stage with Various Patient and Payer Events in July

    NEW YORK, July 07, 2022 (GLOBE NEWSWIRE) -- As part of its ongoing commitment to raise awareness of both the unique challenges faced by people living with IgA nephropathy and of the resources and support required to help them navigate their journey, Calliditas Therapeutics US, a wholly owned affiliate of Sweden-based Calliditas Therapeutics AB focused on advancing care and treatment for rare kidney disease, recognizes and is supporting various events this month. IgA nephropathy, or IgAN, is a pr

  • GlobeNewswire

    Celularity Appoints Industry Leader Diane Parks to its Board of Directors

    Pharmaceutical and Biotech Industry Veteran Brings Significant Strategic Development and Commercialization Expertise Launching New Cellular TherapiesFLORHAM PARK, N.J., June 03, 2022 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a clinical-stage biotechnology company developing placental-derived off-the-shelf allogeneic cell therapies, today announced the appointment of Diane Parks to its Board of Directors. Ms. Parks, an executive with deep experience in the commercializati

  • GlobeNewswire

    Calliditas Therapeutics Launches an Online Patient Platform

    This launch coincides with the inaugural IgAN Awareness DaySTOCKHOLM, Sweden, May 14, 2022 (GLOBE NEWSWIRE) -- Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced the launch of IgAN Connect, a new online platform to provide resources to people living with IgA nephropathy, or IgAN, a chronic autoimmune disease. provides individuals who have just been diagnosed with IgA nephropathy, those who have been living with the disease for many y